This correction improved the differentiation and maturation of SC-β cells relative to uncorrected isogenic cells, including their ability to secrete insulin in a dynamic manner following stimulation with glucose in vitro, and it reversed diabetes following the transplantation of corrected cells into a diabetic mouse. The gene discussed is INS; the disease is diabetes mellitus.